<DOC>
	<DOCNO>NCT02403622</DOCNO>
	<brief_summary>The overarch objective study address knowledge gap regard short-term long-term safety fecal microbiota transplant ( FMT ) . The design prospective , open-label , multi-center longitudinal cohort study assess short- long-term safety FMT well clinical resolution diarrhea among 150 patient 3 episode clostridium difficile infection ( CDI define 3 unformed stool 24 hour 2 consecutive day either positive stool test CDI pseudomembranes colonoscopy/sigmoidoscopy ) . Subjects adult outpatient refer one study center least three recurrent episode CDI previous treatment least one 10-day course oral vancomycin fidaxomicin . After FMT colonoscopy/sigmoidoscopy enema , patient follow prospectively monitor clinical resolution adverse event : 3 day ( telephone ) , 3 week ( clinical assessment ) , 8 week ( telephone ) , 6 month ( telephone ) , 12 month ( telephone ) FMT . Subjects recur offer second FMT colonoscopy different donor . Microbiome analysis conduct stool sample baseline 5 follow-up interval .</brief_summary>
	<brief_title>Safety FMT : OpenBiome Outcomes Longitudinal Follow-up ( STOOL ) Recurrent Clostridium Difficile Infection</brief_title>
	<detailed_description />
	<criteria>Adult ( least 18 year age ) Outpatient Third document CDI episode Unable maintain CDI cure standard therapy oral vancomycin fidaxomicin Previous treatment least one course tapered/pulse vancomycin Inability taper stop vancomycin fidaxomicin without develop diarrhea require antibiotic therapy . Improvement CDI symptom vancomycin fidaxomicin Unable comply study followup procedure travel clinical site followup visit discretion MD Unable provide inform consent discretion MD Participating another clinical trial Pregnant nursing currently plan pregnancy next 1 year Evidence toxic megacolon gastrointestinal perforation Peripheral white blood cell count &gt; 30 x 109/L and/or temperature &gt; 38 degree Celsius Admission intensive care unit within prior 7 day reason Previously undergone FMT Severely immunocompromised patient Documented history ( self physician identify ) HIV infection cluster differentiation 4 ( CD4 ) count AIDSdefining diagnose Inherited/primary immune disorder Immunosuppressant medication Neutropenia absolute neutrophil count ( ANC ) &lt; 0.5 x 109/L Active gastroenteritis due infectious cause CDI Short gut syndrome Colostomy Ascites Endstage liver disease Untreated , insitu colorectal cancer Irritable bowel syndrome Inflammatory bowel disease include Crohn 's disease ulcerative colitis Microscopic colitis include collagenous colitis lymphocytic colitis Severe food allergy ( anaphylaxis ) confirm exclude donor 's diet within five day prior donation Anorectal disorder/severe rectal sphincter tone abnormality inability retain enema material Unable unwilling tolerate colonoscopy/sigmoidoscopy , colonoscopy prep , enema reason discretion MD Severe underlie disease patient expect survive subsequent 12 month discretion MD . Any condition , opinion MD , treatment may pose health risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>